Dr. Russell Lonser, Director of the Gene Therapy Institute, gives a historical overview and provides insight on planning for the future of gene therapy.
May 25, 2023
“Our findings could lead to a better understanding of how ALS develops in people who have this mutation,” said principal investigator Stephen Kolb, MD, PhD, professor of neurology and biological chemistry and pharmacology at Ohio State.
May 24, 2023
Ohio State scientist is studying a novel gene therapy model that could lead to treatment for widespread neurological diseases.
October 17, 2022
